secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001193125-22-209439
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen Q2 revenue $207.6M (+27% YoY); raises FY 2022 guidance
---------------------------------------------------------------

- Q2 revenue $207.6M, up 27% as reported, 32% constant currency; organic growth 29%.
- GAAP diluted EPS $0.88 vs $0.64; adjusted EPS $0.91 vs $0.79, both YoY increases.
- FY 2022 revenue guidance raised to $790-$810M from $770-$800M; adjusted EPS raised to $3.13-$3.20.
- Base business grew 41% in Q2, led by Filtration and Chromatography franchises.
- Cash $596.5M at June 30, 2022; gross margin 58.5% GAAP, 58.7% adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312522209439/0001193125-22-209439-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312522209439/d371357d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-209439

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer